Implications of p53 gene mutations on patient survival in transitional cell carcinoma of the bladder: A long-term study

Urologic Oncology: Seminars and Original Investigations

Volumn 26, Issue 6, 2008, Pages 620-626

  Salinas Sánchez, Antonio S ^a   Lorenzo Romero, Juan G ^a   Giménez Bachs, José M ^a   Sánchez Sánchez, Francisco ^b   Donate Moreno, María J ^a   Rubio del Campo, Antonio ^b   Hernández Millán, Ibrahim R ^a   Segura Martín, Miguel ^a   Atienzar Tobarra, Manuel ^a   Escribano Martínez, Julio ^b  

^a Hospital and University Complex of Albacete   (Spain)

^b UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

Bladder tumor; Immunohistochemistry; p53 gene; Prognosis; Survival

Indexed keywords

DNA; MONOCLONAL ANTIBODY; PROTEIN P53;

AGED; ARTICLE; BLADDER CARCINOMA; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; EXON; FEMALE; FOLLOW UP; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SINGLE STRAND CONFORMATION POLYMORPHISM; SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; TRANSITIONAL CELL CARCINOMA;

AGED; CARCINOMA, TRANSITIONAL CELL; FEMALE; FOLLOW-UP STUDIES; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; PROPORTIONAL HAZARDS MODELS; URINARY BLADDER NEOPLASMS;

EID: 55249109226     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2007.07.011     Document Type: Article

References (21)

1. Mitra A.P., Datar R.H., and Cote R.J. Molecular staging of bladder cancer. BJU Int 96 (2005) 7-12
2. Lorenzo-Romero J.G., Salinas-Sánchez A.S., Giménez-Bachs J.M., et al. Prognostic implications of p53 gene mutation in bladder tumors. J Urol 169 (2003) 492-499
3. Cordon-Cardo C., and Reuter V.E. Alterations of suppressor genes in bladder cancer. Semin Diagn Pathol 4 (1997) 123-132
4. Esrig D., Elmajian D., Groshen S., et al. Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med 331 (1994) 1259-1262
5. Bergh J., Norberg T., Sjogren S., et al. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med 1 (1995) 1029-1034
6. Berns A. Cancer genetics. Is p53 the only real tumor suppressor gene?. Curr Biol 4 (1994) 137-139
7. Alvarez-Kindelan J., Lopez-Beltran A., and Requena-Tapia M.J. Biología molecular en el cáncer vesical. Acta Urol Esp 24 (2000) 604-625
8. Keegan P.E., Lunec J., and Neal D.E. p53 and p53-regulated genes in bladder cancer. Br J Urol 82 (1998) 710-720
9. Cordon-Cardo C., Zhang Z.F., Dalbagni G., et al. Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors. Cancer Res 57 (1997) 1217-1221
10. Cordon-Cardo C. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol 147 (1995) 545-560
11. Llopis J., Alcaraz A., Ribal M.J., et al. p53 Expression predicts progression and poor survival in T1 bladder tumors. Eur Urol 37 (2000) 644-653
12. Greenblatt M.S., Bennett W.P., Hollstein M., et al. Mutations in the p53 suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 54 (1994) 4855-4878
13. Schmitz-Drager B.J., Goebell P.J., Ebert T., et al. p53 Immunohistochemistry as a prognostic marker in bladder cancer. Playground for urology scientists?. Eur Urol 38 (2000) 691-699
14. Van Brussel J.P., and Mickisch G.H. Prognostic factors in renal cell and bladder cancer. BJU Int 83 (1999) 902-909
15. Uchida T., Wada C., Ishida H., et al. p53 Mutations and prognosis in bladder tumors. J Urol 153 (1995) 1097-1104
16. Dahse R., Utting M., Werner W., et al. Prognostic significance of mutations in the p53 gene in superficial bladder cancer. Oncol Rep 7 (2000) 931-936
17. Moonen P.M., van Balken-Ory B., Kiemeney L.A., et al. Prognostic value of p53 for high risk superficial bladder cancer with long-term follow-up. J Urol 177 (2007) 80-83
18. Friedrich M.G., Riethdorf S., Erbersdobler A., et al. Relevance of p53 gene alterations for tumor recurrence in patients with superficial transitional cell carcinoma of the bladder. Eur Urol 39 (2001) 159-166
19. Schier B.P., Vriesema J.L., Witjes J.A., et al. The predictive value of p53, p27(kip1), and α-catenin for progression in superficial bladder carcinoma. Eur Urol 50 (2006) 76-82
20. Gao P.J., Uchida T., Wang C., et al. Relationship between p53 gene mutation and protein expression: Clinical significance in transitional cell carcinoma of the bladder. Int J Oncol 16 (2000) 469-475
21. Salinas-Sánchez A.S., Atienzar-Tobarra M., Lorenzo-Romero J.G., et al. Sensitivity and specificity of p53 protein detection by immunohistochemistry in patients with urothelial bladder carcinoma. Urol Int 79 (2007) 321-327